P. Merle

1.2k total citations
55 papers, 539 citations indexed

About

P. Merle is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, P. Merle has authored 55 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in P. Merle's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Diagnosis and Treatment (14 papers) and Lung Cancer Research Studies (10 papers). P. Merle is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Diagnosis and Treatment (14 papers) and Lung Cancer Research Studies (10 papers). P. Merle collaborates with scholars based in France, United States and Japan. P. Merle's co-authors include Denis Moro‐Sibilot, Pierre-Jean Souquet, S. Couraud, Christian Brambilla, M. Pérol, Anne‐Claire Toffart, Claire Tissot, Marc Filaire, Jiří Zavadil and Magali Olivier and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

P. Merle

53 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Merle France 13 239 213 154 143 52 55 539
Gerd Wunderlich Germany 20 270 1.1× 173 0.8× 37 0.2× 127 0.9× 74 1.4× 53 852
Katsumi Tomiyoshi Japan 17 223 0.9× 80 0.4× 124 0.8× 171 1.2× 75 1.4× 58 899
Jong Chul Park United States 14 278 1.2× 327 1.5× 83 0.5× 105 0.7× 105 2.0× 59 727
K. Newbold United Kingdom 16 227 0.9× 202 0.9× 95 0.6× 119 0.8× 171 3.3× 33 803
David T. Marshall United States 16 241 1.0× 196 0.9× 83 0.5× 196 1.4× 83 1.6× 38 748
Hiromasa Sakamoto Japan 11 162 0.7× 78 0.4× 41 0.3× 92 0.6× 28 0.5× 26 391
Nimesh R. Patel United States 13 168 0.7× 108 0.5× 31 0.2× 97 0.7× 80 1.5× 33 557
Jih‐Fang Hsieh Taiwan 17 199 0.8× 176 0.8× 38 0.2× 85 0.6× 160 3.1× 47 694
Jean‐Marc Vrigneaud France 16 141 0.6× 85 0.4× 46 0.3× 91 0.6× 80 1.5× 42 670

Countries citing papers authored by P. Merle

Since Specialization
Citations

This map shows the geographic impact of P. Merle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Merle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Merle more than expected).

Fields of papers citing papers by P. Merle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Merle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Merle. The network helps show where P. Merle may publish in the future.

Co-authorship network of co-authors of P. Merle

This figure shows the co-authorship network connecting the top 25 collaborators of P. Merle. A scholar is included among the top collaborators of P. Merle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Merle. P. Merle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pereira, Bruno, et al.. (2023). Oligroprogression sous nivolumab du cancer bronchique non à petites cellules métastatiques traitées par radiothérapie. Bulletin du Cancer. 110(12). 1234–1243. 1 indexed citations
3.
Balayssac, David, Bruno Pereira, Carine Chaleteix, et al.. (2023). Satisfaction of Cancer Patients Treated with Oral Anticancer Medications regarding Dispensing by Community Pharmacists: A Cross-Sectional Study. European Journal of Cancer Care. 2023. 1–9.
4.
Garcia, Jessica, Arnaud Gauthier, Daniel L. Edelstein, et al.. (2021). Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAMTM EGFR V2 and NGS Technologies. Molecular Diagnosis & Therapy. 25(2). 239–250. 8 indexed citations
5.
Selvy, Marie, Bruno Pereira, Nicolas Kerckhove, et al.. (2021). Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists’ professional practices. Supportive Care in Cancer. 29(7). 4033–4043. 14 indexed citations
6.
Bourbao-Tournois, Céline, et al.. (2021). Long-term evaluation of the impact of delivery modalities on anal continence in women with Crohn's disease. Journal of Visceral Surgery. 159(5). 353–361. 2 indexed citations
7.
Baldacci, Simon, Benjamin Besse, Virginie Avrillon, et al.. (2020). 1303P Lorlatinib for advanced ALK+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort. Annals of Oncology. 31. S843–S843. 1 indexed citations
8.
Levra, Matteo Giaj, M. Duruisseaux, Carole Schwebel, et al.. (2019). Impact of systematic advanced care planning in lung cancer patients: A prospective study. Respiratory Medicine and Research. 77. 11–17. 5 indexed citations
9.
Filaire, Marc, Ruddy Richard, Patrick Bailly, et al.. (2015). Prophylactic tracheotomy and lung cancer resection in patient with low predictive pulmonary function: a randomized clinical trials.. PubMed. 4(4). 40–40. 6 indexed citations
10.
Jeannin, G., P. Merle, Henri Janicot, et al.. (2015). Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study.. PubMed. 4(4). 39–39. 5 indexed citations
11.
Moro‐Sibilot, Denis, Clarisse Audigier-Valette, P. Merle, et al.. (2015). Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study). Lung Cancer. 89(2). 139–145. 8 indexed citations
12.
Tissot, Claire, Anne‐Claire Toffart, Stéphanie Villar, et al.. (2015). Circulating free DNA concentration is an independent prognostic biomarker in lung cancer. European Respiratory Journal. 46(6). 1773–1780. 99 indexed citations
13.
Merle, P., Marine Gueugneau, Marie‐Paule Teulade‐Fichou, et al.. (2015). Highly efficient radiosensitization of human glioblastoma and lung cancer cells by a G-quadruplex DNA binding compound. Scientific Reports. 5(1). 16255–16255. 28 indexed citations
14.
Toffart, Anne‐Claire, Denis Moro‐Sibilot, S. Couraud, et al.. (2014). Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study. BMC Cancer. 14(1). 989–989. 6 indexed citations
15.
Toffart, Anne‐Claire, Jean‐François Timsit, S. Couraud, et al.. (2013). Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study). Lung Cancer. 83(2). 182–188. 15 indexed citations
16.
Merle, P., Bertrand Evrard, Anne Petitjean, et al.. (2011). Telomere Targeting with a New G4 Ligand Enhances Radiation-Induced Killing of Human Glioblastoma Cells. Molecular Cancer Therapeutics. 10(10). 1784–1795. 32 indexed citations
17.
Ines, D. Da, P. Chabrot, L. Cassagnes, et al.. (2008). Traitement endovasculaire du syndrome cave supérieur d’origine néoplasique : à propos de 34 patients. Journal de Radiologie. 89(7-8). 881–890. 8 indexed citations
18.
Morin, Franck, Quan Le Tran, Jean‐Charles Soria, et al.. (2007). P3-071: Respiratory symptoms improvement in non-resectable adenocarcinoma with bronchioloalveolar carcinoma features (ADC-BAC) treated with gefitinib: Quality of Life analysis of the IFCT-0401 trial. Journal of Thoracic Oncology. 2(8). S708–S708. 1 indexed citations
19.
Dalle, Stéphane, P. Merle, C Gouillat, & L. Thomas. (2006). Carcinome hépatocellulaire de petite taille révélé par un prurigo. Annales de Dermatologie et de Vénéréologie. 133(3). 243–245. 4 indexed citations
20.
Chabrot, P., L. Cassagnes, P. Merle, et al.. (1970). [Endovascular treatment of SVC syndrome from neoplastic origin: a review of 34 cases].. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerd Wunderlich Breakdown of academic impact, for papers by Katsumi Tomiyoshi Breakdown of academic impact, for papers by Jong Chul Park Breakdown of academic impact, for papers by K. Newbold Breakdown of academic impact, for papers by David T. Marshall Breakdown of academic impact, for papers by Hiromasa Sakamoto Breakdown of academic impact, for papers by Nimesh R. Patel Breakdown of academic impact, for papers by Jih‐Fang Hsieh Breakdown of academic impact, for papers by Jean‐Marc Vrigneaud
Rankless by CCL
2026